261 related articles for article (PubMed ID: 30413323)
1. Natural history of papillary thyroid microcarcinoma: Kinetic analyses on tumor volume during active surveillance and before presentation.
Miyauchi A; Kudo T; Ito Y; Oda H; Yamamoto M; Sasai H; Higashiyama T; Masuoka H; Fukushima M; Kihara M; Miya A
Surgery; 2019 Jan; 165(1):25-30. PubMed ID: 30413323
[TBL] [Abstract][Full Text] [Related]
2. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
Sasaki T; Miyauchi A; Ito Y; Kudo T; Kanemura N; Sano T; Kawano S; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Miya A
Thyroid; 2021 Feb; 31(2):217-223. PubMed ID: 32664805
[No Abstract] [Full Text] [Related]
3. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
Kwon H; Oh HS; Kim M; Park S; Jeon MJ; Kim WG; Kim WB; Shong YK; Song DE; Baek JH; Chung KW; Kim TY
J Clin Endocrinol Metab; 2017 Jun; 102(6):1917-1925. PubMed ID: 28323932
[TBL] [Abstract][Full Text] [Related]
4. Kinetic Analysis of Growth Activity in Enlarging Papillary Thyroid Microcarcinomas.
Ito Y; Miyauchi A; Kudo T; Higashiyama T; Masuoka H; Kihara M; Miya A
Thyroid; 2019 Dec; 29(12):1765-1773. PubMed ID: 31650907
[No Abstract] [Full Text] [Related]
5. Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
Surgery; 2024 Apr; 175(4):1089-1094. PubMed ID: 38142143
[TBL] [Abstract][Full Text] [Related]
6. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.
Tuttle RM; Fagin JA; Minkowitz G; Wong RJ; Roman B; Patel S; Untch B; Ganly I; Shaha AR; Shah JP; Pace M; Li D; Bach A; Lin O; Whiting A; Ghossein R; Landa I; Sabra M; Boucai L; Fish S; Morris LGT
JAMA Otolaryngol Head Neck Surg; 2017 Oct; 143(10):1015-1020. PubMed ID: 28859191
[TBL] [Abstract][Full Text] [Related]
7. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Kim TY; Lee JH; Kim WB; Shong YK; Chung KW; Baek JH; Kim WG
Thyroid; 2019 May; 29(5):642-649. PubMed ID: 30864894
[No Abstract] [Full Text] [Related]
8. Active Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns.
Tuttle RM; Fagin J; Minkowitz G; Wong R; Roman B; Patel S; Untch B; Ganly I; Shaha A; Shah J; Li D; Bach A; Girshman J; Lin O; Cohen M; Cohen JM; Cracchiolo J; Ghossein R; Sabra M; Boucai L; Fish S; Morris L
Thyroid; 2022 Nov; 32(11):1337-1345. PubMed ID: 36178355
[No Abstract] [Full Text] [Related]
9. Clinicopathologic Factors and Thyroid Nodule Sonographic Features for Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 1204 Patients.
Wang WH; Xu SY; Zhan WW
J Ultrasound Med; 2016 Nov; 35(11):2475-2481. PubMed ID: 27794131
[TBL] [Abstract][Full Text] [Related]
10. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea.
Jin M; Kim HI; Ha J; Jeon MJ; Kim WG; Lim DJ; Kim TY; Chung JH; Shong YK; Kim TH; Kim WB
Thyroid; 2021 Oct; 31(10):1494-1501. PubMed ID: 34225475
[No Abstract] [Full Text] [Related]
11. Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance.
Lin JF; Jonker PKC; Cunich M; Sidhu SB; Delbridge LW; Glover AR; Learoyd DL; Aniss A; Kruijff S; Sywak MS
Surgery; 2020 Jan; 167(1):110-116. PubMed ID: 31543327
[TBL] [Abstract][Full Text] [Related]
12. Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital.
Ito Y; Miyauchi A; Kudo T; Ota H; Yoshioka K; Oda H; Sasai H; Nakayama A; Yabuta T; Masuoka H; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Thyroid; 2016 Jan; 26(1):156-60. PubMed ID: 26670937
[TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid microcarcinoma might progress during pregnancy.
Shindo H; Amino N; Ito Y; Kihara M; Kobayashi K; Miya A; Hirokawa M; Miyauchi A
Thyroid; 2014 May; 24(5):840-4. PubMed ID: 24397849
[TBL] [Abstract][Full Text] [Related]
14. Tumor growth manifested in two-fifths of low-risk papillary thyroid microcarcinoma patients during active surveillance: data from a tertiary center in China.
Le K; Jin L; Zhong F; Huang X; Zhou L; Zhou J; Xie L
Front Endocrinol (Lausanne); 2024; 15():1359621. PubMed ID: 38577570
[TBL] [Abstract][Full Text] [Related]
15. Interobserver Reproducibility in Sonographic Measurement of Diameter and Volume of Papillary Thyroid Microcarcinoma.
Chung SR; Choi YJ; Lee SS; Kim SO; Lee SA; Jeon MJ; Kim WG; Lee JH; Baek JH
Thyroid; 2021 Mar; 31(3):452-458. PubMed ID: 33287640
[No Abstract] [Full Text] [Related]
16. The dilemma of papillary thyroid microcarcinoma management. To operate or not to operate, that is the question.
Galofré JC
Endocrinol Diabetes Nutr (Engl Ed); 2019 Oct; 66(8):469-471. PubMed ID: 32565060
[No Abstract] [Full Text] [Related]
17. Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance.
Miyauchi A; Kudo T; Ito Y; Oda H; Sasai H; Higashiyama T; Fukushima M; Masuoka H; Kihara M; Miya A
Surgery; 2018 Jan; 163(1):48-52. PubMed ID: 29103582
[TBL] [Abstract][Full Text] [Related]
18. Active Surveillance in Adults with Low-Risk Papillary Thyroid Microcarcinomas: A Prospective Study.
Rosario PW; Mourão GF; Calsolari MR
Horm Metab Res; 2019 Nov; 51(11):703-708. PubMed ID: 31683339
[TBL] [Abstract][Full Text] [Related]
19. Papillary thyroid microcarcinoma: optimal management versus overtreatment.
Walgama E; Sacks WL; Ho AS
Curr Opin Oncol; 2020 Jan; 32(1):1-6. PubMed ID: 31633497
[TBL] [Abstract][Full Text] [Related]
20. Incidental and Non-incidental Papillary Thyroid Microcarcinoma in Denmark 1996-2015: A national study on incidence, outcome and thoughts on active surveillance.
Reinke R; Mathiesen JS; Larsen SR; Hahn CH; Pedersen HB; Bentzen J; Schytte S; Godballe C; Londero SC;
Cancer Epidemiol; 2019 Jun; 60():46-50. PubMed ID: 30909152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
